General Information
DRAVP ID DRAVPs015
Peptide Name P21S8ZF
Sequence LDLTYEZLSLQXVVKXLNESF
Sequence Length 21
Original Sequence DLTYEZLSLQAVVKALNESF
Source Synthetic construct (From S2 unit of MERS-Cov)
Validation Experimentally Validated
Activity Information
Target Organism MERS-CoV
Assay Inhibition of MERS-CoV S-Protein-Mediated Cell–Cell Fusion Assay
Activity
Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry
Cytotoxicity No cytotoxicity information found in the reference(s) presented
Binding Target membrane
Mechanism The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.
Structure Information
Linear/Cyclic Cyclic
N-terminal Modification Acetylation
C-terminal Modification Carboxyamidation
Special Amino Acid and Stapling Position ①The 'X' (position: 12 and 16) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (12) and X (16) are cross-linked by hydrocarbon stapling.,The 'Z' at position 7 indicates R8 ((R)-octenyl alanine)
Structure Description Not Available
Stereochemistry L
Literature Information
Literature 1
Title Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors
Pubmed ID 29442512
Reference Journal of medicinal chemistry, 61(5), 2018–2026.
Author Wang, C., Xia, S., Zhang, P., Zhang, T., Wang, W., Tian, Y., Meng, G., Jiang, S., & Liu, K. (2018).